News
Abu Dhabi is set to revolutionise cancer care in the region with the launch of a world-class heavy ion therapy facility — one of only 15 of its kind globally. The cutting-edge centre will be ...
Get Instant Summarized Text (Gist) New atomic data reveal the impact of charged ions from coronal mass ejections (CMEs) on space weather. Using a high-resolution reaction microscope spectrometer ...
In this article, we are going to look at where Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...
TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00. The company’s shares closed yesterday at $28.68.
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...
BELTSVILLE, Md., March 26, 2025 /PRNewswire/ -- ION Storage Systems (ION) has successfully produced its first multi-layer ceramic solid-state battery (SSB) cell on its semi-automated production ...
Get Instant Summarized Text (Gist) The g factor of boron-like tin ions (118 Sn 45+) was measured with unprecedented precision, providing a stringent test of quantum electrodynamics (QED).The ...
The fires that swept through Los Angeles County in January left behind more than 1 million pounds of damaged lithium-ion batteries, ranging from slim capsules inside iPhones to the brick-like ...
ROME, April 9 (Reuters) - Italy is seeking 1.2 billion euros ($1.3 billion) from fintech group ION following a probe by prosecutors in the northern city of Bologna into alleged tax evasion over ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results